SHIJIAZHUANG CREADY PHARMACEUTICAL R AND D INC

Overview

SHIJIAZHUANG CREADY PHARMACEUTICAL R AND D INC is an active pharmaceutical ingredient (API) supplier with 2 active FDA Type II Drug Master Files, covering IBUPROFEN GRANULES DC 85%; METFORMIN HYDROCHLORIDE GRANULES.

API / Drug Master Files

SHIJIAZHUANG CREADY PHARMACEUTICAL R AND D INC holds 2 active (2 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• METFORMIN HYDROCHLORIDE GRANULESActive2023-12-19
• IBUPROFEN GRANULES DC 85%Active2023-12-12

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to SHIJIAZHUANG CREADY PHARMACEUTICAL R AND D INC in our records. PharmaTek screens the full directory against live FDA enforcement data.